Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057704 · ClinicalTrials.gov registry record · Phase 4
Comparison of Two Techniques of IV Lidocaine on Propofol Injection Pain
A Phase 4 study of Injections, Intravenous, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03057704: Completed Phase 4 study of Injections, Intravenous, sponsored by Wake Forest University Health Sciences.
NCT03057704 is a Phase 4 study of Injections, Intravenous that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03057704, a Phase 4 study of Injections, Intravenous, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Intravenous lidocaine is commonly given through an intravenous (IV) line prior to injection of propofol to reduce the amount of pain during propofol injection. The investigators want to study if giving the lidocaine through the IV while the forearm on the same limb has a tourniquet applied to it to prevent "washing out" of the lidocaine prior to propofol injection helps reduce propofol injection pain.
Primary Outcome
Patient's verbal rating of pain during injection (see link to study protocol) We used a Verbal Rating Scale from the patient that self-described discomfort level during injection using question: How would you rate your pain using None, Mild, Moderate, Severe and record it on this 4-point scale: * None (0) * Mild (1) * Moderate (2) * Severe (3) None is no pain (best outcome) and Severe is worst pain possible (worst outcome).
Conditions Studied
Interventions
- DRUG Lidocaine injection flushed
- DRUG Lidocaine injection tourniquet
Study Locations (1)
North Carolina
- North Carolina Baptist Hospital - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-12-05 |
| Est. Completion | 2017-01-20 |
| Phase | Phase 4 |
What the finished NCT03057704 record still lists
NCT03057704 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Injections, Intravenous appearing as the primary indexed condition, and to 2 interventions - of which Lidocaine injection flushed is the first listed.
NCT03057704 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03057704 about?
NCT03057704 is a clinical study titled "Comparison of Two Techniques of IV Lidocaine on Propofol Injection Pain". Intravenous lidocaine is commonly given through an intravenous (IV) line prior to injection of propofol to reduce the amount of pain during propofol injection. The investigators want to study if giving the lidocaine through the IV while the forearm on the same limb has a tourniquet applied to it to ...
What is the current status of trial NCT03057704?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2016-12-05. Estimated completion is 2017-01-20.
What conditions does trial NCT03057704 study?
This clinical trial studies the following conditions: Injections, Intravenous.
What interventions are being tested in trial NCT03057704?
The interventions under investigation include: Lidocaine injection flushed (DRUG), Lidocaine injection tourniquet (DRUG).
Who is sponsoring clinical trial NCT03057704?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03057704 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03057704's enrollment target sits among peer trials
50 1255th of 2000 higher than 679 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI